Cardiovascular Activities of of the bradykinin system
All the components of the kallikrein-kinin system are located in the cardiac muscle andits deficiency may lead to cardiac dysfunction. In recent years, numerous observationsobtained from clinical and experimental models of diabetes, hypertension, cardiacfailure, ischemia, myocardial infarction, and...
Saved in:
Main Author: | Jagdish N. Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2008.53 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
by: J. N. Sharma, et al.
Published: (2006-01-01) -
Interaction of Bradykinin and B2 Bradykinin Receptor Antagonists with Colloidal Au Surface Explored by Surface-Enhanced Raman Scattering
by: Dominika Skołuba, et al.
Published: (2014-01-01) -
Bradykinin B1 receptor signaling triggers complement activation on endothelial cells
by: Ingrid Lopatko Fagerström, et al.
Published: (2025-02-01) -
Intra-pancreatic release of bradykinin during the course experimental pancreatitis in rat
by: P. Jönsson, et al.
Published: (1996-01-01) -
Bradykinin Type-2 Receptor Expression Correlates with Age and Is Subjected to Transcriptional Regulation
by: Inka Liesmaa, et al.
Published: (2012-01-01)